SA PRO
Free Account
Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 160% higher.

Bear Case
$10.00
+29%
Consensus
$20.14
+160%
Bull Case
$30.00
+288%
Price Range5 analysts
Low
Consensus
High
$10.00
$30.00
Current Target
Current Price
$7.74
Upside to Target
$12.41

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 13, 2026H.C. Wainwright
Lexeo Therapeutics price target lowered to $10 from $13 at H.C. Wainwright
Target:$10.00
+23.2%from $8.12
Dec 17, 2025Raymond James
Lexeo Therapeutics initiated with a Strong Buy at Raymond James
Target:$25.00
+174.4%from $9.11
Dec 10, 2025Oppenheimer
Oppenheimer Reiterates Outperform Rating on Lexeo Therapeutics (LXEO)
Target:$20.00
+110.4%from $9.51
Nov 20, 2025Cantor Fitzgerald
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Target:$19.00
+109.0%from $9.09
Oct 21, 2025H.C. Wainwright
Lexeo Therapeutics price target lowered to $13 from $15 at H.C. Wainwright
Target:$13.00
+41.0%from $9.22
Oct 15, 2025Guggenheim
Lexeo Therapeutics initiated with a Buy at Guggenheim
Target:$30.00
+252.9%from $8.50
Oct 7, 2025Chardan Capital
Lexeo Therapeutics price target raised to $17 from $15 at Chardan
Target:$17.00
+106.1%from $8.25
Oct 7, 2025H.C. Wainwright
Lexeo Therapeutics price target raised to $15 from $9 at H.C. Wainwright
Target:$15.00
+81.8%from $8.25
Oct 7, 2025Leerink Partners
Lexeo Therapeutics price target raised to $20 from $9 at Leerink
Target:$20.00
+142.4%from $8.25
Jun 12, 2024Robert W. Baird
Lexeo Therapeutics initiated with an Outperform at Baird
Target:$28.00
+53.9%from $18.19

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance